Search Results
Results found for "GPCR training program"
- Prostaglandin signaling in ciliogenesis and development
Many G-protein-coupled receptors (GPCRs) including EP4 are localized in cilia for modulating cAMP signaling
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
The turning point came during her master’s program in pharmacogenomics. And GPCR pharmacology isn’t just an academic pursuit—it’s essential to understanding and responding to
- Chemokine receptor-targeted drug discovery: progress and challenges
Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in of chemokine receptors which are regulated by globular protein ligands, unlike most of the class A GPCRs
- Applications of Cryo-EM in small molecule and biologics drug design
cryo-EM has enabled insights into important drug target families such as G protein-coupled receptors (GPCRs
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
Retrograde trans-synaptic rabies virus tracing revealed that postsynaptic cAMP signaling is required Given that postsynaptic latrophilin adhesion-GPCRs drive synapse formation and produce cAMP, we suggest
- Disentangling bias between G q, GRK2, and arrestin3 recruitment to the M 3 muscarinic acetylcholine
G protein-coupled receptors (GPCRs) transmit extracellular signals to the inside by activation of intracellular
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
characterize ligand interactions with cell surface membrane proteins such as G-protein coupled receptors (GPCRs
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
"The effects of the neurohormone melatonin are mediated by the activation of the GPCRs MT1 and MT2 in
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
their functional activities are achieved by binding to the cell surface G protein-coupled receptors (GPCRs
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
is a key protein that mediates desensitization and internalization of G protein-coupled receptors (GPCRs
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
dependent kinase inhibitor 1B; CQ: chloroquine; E2F1: E2F transcription factor 1; FBS: fetal bovine serum; GPCRs
- New role of β-arrestins in MOR signaling
Opioid receptors belong to class A of G protein-coupled receptors or GPCRs and signaled mainly through Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Exendin-4, and possibly through G protein-coupled receptors (GPCRs), increases levels of cAMP and upregulates
- The Five Traps of Ignoring Kinetics
Think of it like catching a train: two passengers have tickets (affinity), but only the one who sprints Unlock “Kinetics: Advanced Applications” Only in Terry’s Corner Why Terry’s Corner Most pharmacology training
- The Real Cost of Strategic Overload in Biotech
Each program appears to increase optionality and reduce risk. 👉 This is where strategic overload begins When multiple programs advance at the same time, trade-offs become implicit instead of explicit. The problem is not that there are multiple programs. If one program slows, another might accelerate. Letting go of a program can feel like abandoning potential value.
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
Scientific Thinking — and Why They Break Down in Biotech Operations Leadership 👉 Scientific thinking trains the window of opportunity has often closed. 3️⃣ “Deep analysis leads to better answers” Scientific training
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
They are not there to confirm what works; they are trained to identify what might break later . Because by the time they do, your timelines will stretch, your budgets will strain, and your confidence
- The Moment Biotech Founders Realize the Money Is Gone
It is that biotech founders are trained to trust scientific momentum , while financial risk builds silently
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
PK errors no longer dominate failure statistics, but fundamental blind spots still derail programs Kenakin shows that programs fail when these questions are skipped, deferred, or answered implicitly instead
- Reflections on My PhD Journey: Lessons Learned
In my case, I was fortunate to be part of a program that allowed for lab rotations.
- Curve Shifts Don’t Lie, But Your Eyes Might
Corner Your work demands clarity, speed, and confidence, especially when early decisions determine which programs
- Understanding the Journey: Catherine Demery's Path to Addiction Science
The Spark of Addiction Science After two years in industry, Catherine enrolled in a master’s program
- TeachOpenCADD - A teaching platform for computer-aided drug design
Open source programming packages for cheminformatics and structural bioinformatics are powerful tools
- Why Fundraising Mistakes Kill Strong Biotech Startups
Programs move forward because they sound fundable, not because the data justifies the timing.
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
company mantra Investor communication feels reactive and apologetic Key documents live in the CEO’s brain
- The Hidden Cost of Unclear Biotech Positioning
Over time, this constant adjustment drains confidence and momentum, even when the science is strong.
- How Early Strategic Decision Making Creates Alignment and Better Results
Teams that skip this step carry an invisible scope that slowly drains focus. 4️⃣ How decisions will be













